Open AccessPB1949: ELTROMBOPAG IN CHINESE PATIENTS WITH REFRACTORY OR RELAPSED SEVERE APLASTIC ANEMIA: A NON‐RANDOMIZED, OPEN‐LABEL, MULTICENTER, PHASE II STUDY ASSESSING THE SAFETY AND EFFICACY OF ELTROMBOPAG
Author(s) -
Chang H.,
He G.,
Fu R.,
Li F.,
Han B.,
Li T.,
Liu L.,
Mittal H.,
Jin H.,
Zhang F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850632.68892.3e
Subject(s) - eltrombopag , medicine , clinical endpoint , aplastic anemia , gastroenterology , pancytopenia , refractory (planetary science) , surrogate endpoint , anemia , randomized controlled trial , bone marrow , platelet , immune thrombocytopenia , physics , astrobiology